All the pieces are falling into place.
If anyone thinks that SI and the team have not been in heavy talks with major players - well they're kidding themselves.
The prep work needed is huge and we can rest assured it is happening.
This award is just one more piece, and a very nice one at that, in this very long journey.
I believe FDA approval is the next one we need - before an early halt to the C-19 trial. It just works better for MSB that way.
IMO, MSB is the best bio play on the market today - by a country mile.
Here we go ... fingers and toes crossed
Ann: MSB Wins Fierce Biotech Innovation Award for Remestemcel-L, page-197
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
0.010(0.66%) |
Mkt cap ! $1.741B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.54 | $1.48 | $5.605M | 3.713M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 55197 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.53 | 29782 | 3 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |